Dynamic Basis for Auranofin Drug Recognition by Thiol-Reductases of Human Pathogens and Intermediate Coordinated Adduct Formation with Catalytic Cysteine Residues
Open Access
- 31 May 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 4 (5) , 9593-9602
Abstract
In all the living systems, reactive oxygen species (ROS) metabolism provides resistance against internal and external oxidative stresses. Auranofin (AF), an FDA-approved gold [Au(I)]-conjugated drug, is known to selectively target thiol-reductases, key enzymes involved in ROS metabolism. AF has been successfully tested for its inhibitory activity through biochemical studies, both in vitro and in vivo, against a diverse range of pathogens including protozoa, nematodes, bacteria, and so forth. Cocrystal structures of thiol-reductases complexed with AF revealed that Au(I) was coordinately linked to catalytic cysteines, but the mechanism of transfer of Au(I) from AF to catalytic cysteines still remains unknown. In this study, we have employed computational approaches to understand the interaction of AF with thiol-reductases of selected human pathogens. A similar network of interactions of AF was observed in all the studied enzymes. Also, we have shown that tailor-made analogues of AF can be designed against selective thiol-reductases for targeted inhibition. Molecular dynamics studies show that the AF-intermediates, tetraacetylthioglucose (TAG)-gold, and triethylphosphine (TP)-gold, coordinately linked to one of catalytic cysteines, remain stable in the binding pocket of thiol-reductases for Leishmania infantum and Plasmodium falciparum (PfTrxR). This suggests that the TP and TAG moieties of AF may be sequentially eliminated during the transfer of Au(I) to catalytic cysteines of the receptor.Keywords
Funding Information
- University Grants Commission
- Anusandhan National Research Foundation
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
- Ministry of Education, India
- Indian Institute of Technology Hyderabad
This publication has 36 references indexed in Scilit:
- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and targetNature Medicine, 2012
- A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibitionAmino Acids, 2011
- Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by AuranofinJournal of Biological Chemistry, 2009
- Inhibition of Selenium Metabolism in the Oral Pathogen Treponema denticolaJournal of Bacteriology, 2009
- Differential inhibition of high and low Mrthioredoxin reductases of parasites by organotelluriums supports the concept that low Mrthioredoxin reductases are good drug targetsParasitology, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Correction: Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug TargetPLOS Medicine, 2007
- Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug TargetPLOS Medicine, 2007
- Constant pressure molecular dynamics algorithmsThe Journal of Chemical Physics, 1994
- Intestinal Uptake and Metabolism of Auranofin, a New Oral Gold-Based Antiarthritis DrugScience, 1984